United States Biotechnology & Medical Research

Klotho Neurosciences Inc (KLTO)

Track

Over the past 90 days, Klotho Neurosciences Inc. recorded three insider transactions. CFO Jeff LeBlanc purchased shares valued at $245,280 in July 2026. Conversely, Director Riad El-Dada executed and proposed sales totaling approximately $80,482 in June 2026. These activities represent the most recent insider trading activity for the company.
Ticker: KLTO Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Klotho Neurosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
McGarity Jon
1 purchase — total 100,000 USD
Buy 20 Jul 2026
Value US$3,078,186.95 | Price 134.46 | Shares 37,204
Buy 16 Jul 2026
Value US$571,451.32 | Price 342.21 | Shares 60,440
Sale 25 Jun 2026
Value US$40,547.50 | Price 0.23 | Shares 175,000
Proposed sale 24 Jun 2026
Value US$39,935.00 | Price 0.23 | Shares 175,000
Sale 2 Jul 2024
Value US$368,442.00 | Price 2.05 | Shares 180,000
Sale 1 Jul 2024
Value US$237,617.68 | Price 2.06 | Shares 115,136
Sale 28 Jun 2024
Value US$119,102.70 | Price 2.53 | Shares 47,000
Buy 7 Apr 2022
Value US$375,000.00 | Price 10.00 | Shares 37,500
Buy 4 Apr 2022
Value US$3,775,000.00 | Price 10.00 | Shares 377,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-20 2026-07-20 B Purchase
McGarity Jon
Non-Executive Director
37,204 +47.3%
134.46
US$3,078,187 		37,204 +47.3% 134.46 US$3,078,187
2026-07-17 2026-07-16 B Purchase
LeBlanc Jeff

Chief Financial Officer

Officer
60,440 +11.2%
342.21
US$571,451 		60,440 +11.2% 342.21 US$571,451
2026-06-26 2026-06-25 S Sale
El-Dada Riad Hussein
Non-Executive Director
1,478 +32.5%
362.12
US$764,730 		1,478 +32.5% 362.12 US$764,730
2026-06-24 2026-06-24 PrS Proposed sale
Riad El-Dada

Director

Non-Executive Director
175,000
0.23
US$39,935 		175,000 0.23 US$39,935
2024-07-02 2024-07-02 S Sale
3.7
CHARDAN CAPITAL MARKETS LLC
Large shareholder
180,000 -12.3%
2.05
US$368,442 		180,000 -12.3% 2.05 US$368,442
2024-07-02 2024-07-01 S Sale
3.7
CHARDAN CAPITAL MARKETS LLC
Large shareholder
115,136 -7.3%
2.06
US$237,618 		115,136 -7.3% 2.06 US$237,618
2024-07-02 2024-06-28 S Sale
3.7
CHARDAN CAPITAL MARKETS LLC
Large shareholder
47,000 -2.9%
2.53
US$119,103 		47,000 -2.9% 2.53 US$119,103
2022-04-11 2022-04-07 B Purchase
1.5
Redwoods Capital LLC
Large shareholder
37,500 +1.2%
10.00
US$375,000 		37,500 +1.2% 10.00 US$375,000
2022-04-04 2022-04-04 B Purchase
1.5
Redwoods Capital LLC
Large shareholder
377,500 +14.0%
10.00
US$3,775,000 		377,500 +14.0% 10.00 US$3,775,000
Explore more

More insider trading research around Klotho Neurosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America